~~<i id='8D06C72E3A'><strike id='8D06C72E3A'><tt id='8D06C72E3A'><pre id='8D06C72E3A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

leisure time

author：hotspot 2025-10-02 00:52:05 - browse：47431

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： H5N1 virus can be tracked in retail milk, scientists say

hotspot

knowledge

entertainment

explore

hotspot

JeromeDelay/APJusttwoyearsaftertheWorldHealthOrganization’shistoricrecommendationofthefirstmalariava

WSS

UnitedHealth argues against case alleging wrongful AI care denials

Addressing health care workers' trauma can help fight burnout

WHO recommends second malaria vaccine

Setback for rare diseases as Taysha Gene Therapies pulls back

Lawsuit highlights wrinkle for disputes over surprise medical bills

RSV injection headlines need to be accurate for good uptake

Wikipedia

leisure time

hotspot

Activists slam private health insurers over coverage restrictions

Study points to new risk in gene therapy death of Terry Horgan

Wildfire smoke exposes gaps in outdoor worker protections

Will an HIV vaccine ever be a reality?

BioMarin wins approval for gene therapy to treat hemophilia A

As a primary care physician, here's how I hope to partner with AI

Drug repurposing or repositioning? The language matters

Addressing health care workers' trauma can help fight burnout

Apple is now the first public company to be valued at $3 trillion

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

hotspot

H5N1 virus can be tracked in retail milk, scientists say

Study points to new risk in gene therapy death of Terry Horgan

Nobel honors Karikó and Weissman's enduring partnership

FDA poised to publish guidelines for clinical trial diversity

Lawsuit highlights wrinkle for disputes over surprise medical bills

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

knowledge

entertainment

explore

hotspot